Mendelian randomization analyses clarify the effects of height on cardiovascular diseases

An inverse correlation between stature and risk of coronary artery disease (CAD) has been observed in several epidemiologic studies, and recent Mendelian randomization (MR) experiments have suggested evidence that this association may be causal. However, the extent to which the effect estimated by MR can be explained by established cardiovascular risk factors is unclear, with a recent report suggesting that lung function traits could fully explain the height-CAD effect. To clarify this relationship, we utilized the largest set of genetic instruments for human stature to date, comprising >2,000 genetic variants for height and CAD. In univariable analysis, we confirmed that a one standard deviation decrease in height (~6.5 cm) was associated with a 12.0% increase in the risk of CAD, consistent with previous reports. In multivariable analysis accounting for effects from up to 12 established risk factors, we observed a >3-fold attenuation in the causal effect of height on CAD susceptibility (3.7%, p = 2.1x10-2). We observed minimal effects of lung function traits on CAD risk in our analyses, indicating that these traits are unlikely to explain the residual association between height and CAD risk. In sum, these results suggest that height does not add meaningful clinical impact on CAD risk prediction beyond established risk factors.

[1]  M. Budoff,et al.  Lung Function, Coronary Artery Disease, and Mortality in HIV. , 2019, Annals of the American Thoracic Society.

[2]  J. Pritchard,et al.  Variable prediction accuracy of polygenic scores within an ancestry group , 2019, bioRxiv.

[3]  P. Deloukas,et al.  Mendelian randomisation analyses find pulmonary factors mediate the effect of height on coronary artery disease , 2019, Communications Biology.

[4]  C. Lindgren,et al.  GWAS identifies 14 loci for device-measured physical activity and sleep duration , 2018, Nature Communications.

[5]  Benjamin B. Sun,et al.  New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. , 2018, Nature Genetics.

[6]  Dajiang J. Liu,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[7]  Anthony J. Payne,et al.  Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps , 2018, Nature Genetics.

[8]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[9]  G. Coop,et al.  Reduced signal for polygenic adaptation of height in UK Biobank , 2018, bioRxiv.

[10]  S. Hazen,et al.  HDL-cholesterol, genetics, and coronary artery disease: the myth of the 'good cholesterol'? , 2018, European heart journal.

[11]  F. Windmeijer,et al.  An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings , 2018, bioRxiv.

[12]  M. Dore,et al.  The association of adult height with the risk of cardiovascular disease and cancer in the population of Sardinia , 2018, PloS one.

[13]  D. Lawlor,et al.  Association of Genetic Instrumental Variables for Lung Function on Coronary Artery Disease Risk: A 2-Sample Mendelian Randomization Study , 2018, Circulation. Genomic and precision medicine.

[14]  Anand Rohatgi,et al.  Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk. , 2018, Journal of thoracic disease.

[15]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[16]  S. Yusuf,et al.  Penetrance of polygenic obesity susceptibility loci across the body mass index distribution: an update on scaling effects , 2017, bioRxiv.

[17]  Olena O Yavorska,et al.  MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.

[18]  Christopher R. Gignoux,et al.  Human demographic history impacts genetic risk prediction across diverse populations , 2016, bioRxiv.

[19]  Marcelo P. Segura-Lepe,et al.  Rare and low-frequency coding variants alter human adult height , 2016, Nature.

[20]  James Mariachiara Gretchen A Bin Honor Melanie Léa James Bentham Di Cesare Stevens Zhou Bixby Cowan .  A century of trends in adult human height , 2016, eLife.

[21]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[22]  Manolis Kellis,et al.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease , 2015, Nucleic Acids Res..

[23]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[24]  M. Mills,et al.  Does natural selection favour taller stature among the tallest people on earth? , 2015, Proceedings of the Royal Society B: Biological Sciences.

[25]  J. Danesh,et al.  Genetically determined height and coronary artery disease. , 2015, The New England journal of medicine.

[26]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[27]  E. Barrett-Connor,et al.  Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study. , 2014, Respiratory medicine.

[28]  P. Visscher,et al.  Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.

[29]  P. Visscher,et al.  Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.

[30]  E. Demerath,et al.  Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children , 2011, PLoS medicine.

[31]  S. Thompson,et al.  Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.

[32]  P. Toth.  High-Density Lipoprotein and Cardiovascular Risk , 2004, Circulation.

[33]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[34]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[35]  Jonathan H. Wright,et al.  A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments , 2002 .

[36]  D. Mackinnon,et al.  Equivalence of the Mediation, Confounding and Suppression Effect , 2000, Prevention Science.

[37]  J. Manson,et al.  Height and Incidence of Cardiovascular Disease in Male Physicians , 1993, Circulation.

[38]  Christopher F. Baum,et al.  Enhanced Routines for Instrumental Variables/Generalized Method of Moments Estimation and Testing , 2007 .